PREGNANCY SUMMARY

No reports describing the use of dabigatran etexilate in human pregnancy have been located. The animal data suggest moderate risk, but the absence of human pregnancy experience prevents a more complete assessment of the embryo–fetal risk. Until such data are available, other anticoagulants, such as the low-molecular-weight heparins, appear to be a better choice in pregnancy.